Your browser doesn't support javascript.
loading
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer.
Pud, Dorit; Har-Zahav, Gil; Laitman, Yael; Rubinek, Tami; Yeheskel, Adva; Ben-Ami, Sarah; Kaufman, Bella; Friedman, Eitan; Symon, Zvi; Wolf, Ido.
Affiliation
  • Pud D; Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Breast Cancer Res Treat ; 144(1): 123-31, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24477975
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Genetic Predisposition to Disease / Receptors, Serotonin, 5-HT3 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2014 Document type: Article Affiliation country: Israel Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Genetic Predisposition to Disease / Receptors, Serotonin, 5-HT3 Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2014 Document type: Article Affiliation country: Israel Country of publication: Netherlands